Related Experiment Video
Updated: May 19, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
MiR-10b downregulates the stress-induced cell surface molecule MICB, a critical ligand for cancer cell recognition by
Pinchas Tsukerman1, Noam Stern-Ginossar, Chamutal Gur
1Lautenberg Center for General and Tumor Immunology, The Hebrew University, The BioMedical Research Institute, Hadassah Medical School, Jerusalem, Israel.
Abstract:
Natural killer cells (NK) are a component of innate immunity well known for their potent ability to kill virus-infected or neoplastically transformed cells following stimulation of the NK cell receptor NKG2D. One of the various ligands of NKG2D is MICB, a stress-induced ligand that has been found to be upregulated on the surface of tumor cells. However, there is little knowledge about how this upregulation may occur or how it may be selected against in tumors as a mechanism of immune escape. Here, we report that the metastasis-associated microRNA (metastamir) miR-10b directly binds to the 3' untranslated region of MICB and downregulates its expression. Notably, antagonizing miR-10b action enhanced NKG2D-mediated killing of tumor cells in vitro and enhanced clearance of tumors in vivo. Conversely, overexpression of miR-10b downregulated MICB and impaired elimination of tumor cells. Together, our results define MICB as a novel immune target of miR-10b, implying a direct link between metastasis capability and immune escape from NK cells.
Insights
MicroRNA 10b (miR-10b) targets MICB, a protein on tumor cells, reducing natural killer (NK) cell recognition. Inhibiting miR-10b enhances NK cell anti-tumor activity, suggesting a link between metastasis and immune evasion.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Natural killer (NK) cells are crucial for innate immunity, eliminating infected or cancerous cells via NKG2D receptor activation.
- MICB, an NKG2D ligand upregulated on tumor cells, plays a role in immune escape, but its regulation is poorly understood.
Purpose of the Study:
- To investigate the role of microRNA 10b (miR-10b) in regulating MICB expression on tumor cells.
- To determine the impact of miR-10b on NK cell-mediated tumor cell killing and tumor clearance.
Main Methods:
- Investigated the binding of miR-10b to the 3' untranslated region of MICB mRNA.
- Assessed the effect of miR-10b antagonism and overexpression on MICB levels and NKG2D-mediated tumor cell killing in vitro.
- Evaluated tumor clearance in vivo following manipulation of miR-10b activity.
Main Results:
- miR-10b directly binds to the MICB 3' UTR, downregulating its expression.
- Antagonizing miR-10b increased NKG2D-mediated tumor cell killing in vitro and enhanced tumor clearance in vivo.
- Overexpression of miR-10b reduced MICB levels and impaired tumor cell elimination.
Conclusions:
- MICB is identified as a novel immune target regulated by miR-10b.
- This study reveals a direct link between miR-10b's role in metastasis and tumor immune escape from NK cells.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
MicroRNAs
MicroRNAs
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...

